ibrutinib,zanubrutinib
abbvie,beigene,janssen
['leukemia', 'zanubrutinib', ' ibru', 'alpine']
late breaking abstracts #ash22 final analysis of alpine randomized phase 3 study: zanubrutinib demonstrates superior pfs and orr compared with ibrutinib for treatment of relapsed/refractory chronic lymphocytic leukemia
and sll. 
Mexican Hematologist. Oncohematology; hemostasis and thrombosis. Cruz Azul FC.